Showing results (1101-1110 of 1,155) with videos related to

Sort By:
Pageof 116
Cancer & Metabolism|April 5, 2016
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environmentsBarrie Peck, Zachary T Schug, Qifeng Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2015
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosomeF Favero, N McGranahan, M Salm, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular DiseaseLaura B E Kienhorst, Ellen van Lochem, Wietske Kievit, et al.
Seminars in Arthritis and Rheumatism|November 29, 2021
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working groupMelanie Birger Morillon, Robin Christensen, Jasvinder A Singh, et al.
Seminars in Arthritis and Rheumatism|March 14, 2025
Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Genome Biology|November 20, 2024
Considerations in the search for epistasisMarleen Balvert, Johnathan Cooper-Knock, Julian Stamp, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samplesCushla McKinney, Manuela Fanciulli, Marilyn E Merriman, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Core domain set for studies of acute calcium pyrophosphate crystal arthritis: OMERACT delphi survey to establish consensusYiling Zhang, Sara K Tedeschi, Abhishek Abhishek, et al.
Molecular Cell|December 17, 2020
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRDGraeme Hewitt, Valerie Borel, Sandra Segura-Bayona, et al.
HGG Advances|November 7, 2022
A stop-gain variant in BTNL9 is associated with atherogenic lipid profilesJenna C Carlson, Mohanraj Krishnan, Samantha L Rosenthal, et al.
Pageof 116